142 related articles for article (PubMed ID: 28137366)
1. Somatic mutations in cancer: Stochastic versus predictable.
Gold B
Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():37-46. PubMed ID: 28137366
[TBL] [Abstract][Full Text] [Related]
2. Origins of nonsense mutations in human tumor suppressor genes.
Zhang M; Yang D; Gold B
Mutat Res; 2021; 823():111761. PubMed ID: 34461460
[TBL] [Abstract][Full Text] [Related]
3. Arginine CGA codons as a source of nonsense mutations: a possible role in multivariant gene expression, control of mRNA quality, and aging.
Romanov GA; Sukhoverov VS
Mol Genet Genomics; 2017 Oct; 292(5):1013-1026. PubMed ID: 28523359
[TBL] [Abstract][Full Text] [Related]
4. Origin of mutations in genes associated with human glioblastoma multiform cancer: random polymerase errors versus deamination.
Zhang M; Yang D; Gold B
Heliyon; 2019 Mar; 5(3):e01265. PubMed ID: 30899826
[TBL] [Abstract][Full Text] [Related]
5. Origin of Somatic Mutations in β-Catenin versus Adenomatous Polyposis Coli in Colon Cancer: Random Mutagenesis in Animal Models versus Nonrandom Mutagenesis in Humans.
Yang D; Zhang M; Gold B
Chem Res Toxicol; 2017 Jul; 30(7):1369-1375. PubMed ID: 28578586
[TBL] [Abstract][Full Text] [Related]
6. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
[TBL] [Abstract][Full Text] [Related]
7. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
[TBL] [Abstract][Full Text] [Related]
8. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
9. Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1).
Mancini D; Singh S; Ainsworth P; Rodenhiser D
Am J Hum Genet; 1997 Jul; 61(1):80-7. PubMed ID: 9245987
[TBL] [Abstract][Full Text] [Related]
10. Likelihood models of somatic mutation and codon substitution in cancer genes.
Yang Z; Ro S; Rannala B
Genetics; 2003 Oct; 165(2):695-705. PubMed ID: 14573481
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of nonsense mutations causing human genetic disease.
Mort M; Ivanov D; Cooper DN; Chuzhanova NA
Hum Mutat; 2008 Aug; 29(8):1037-47. PubMed ID: 18454449
[TBL] [Abstract][Full Text] [Related]
12. The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.
Baser ME;
Hum Mutat; 2006 Apr; 27(4):297-306. PubMed ID: 16521120
[TBL] [Abstract][Full Text] [Related]
13. The interaction between cytosine methylation and processes of DNA replication and repair shape the mutational landscape of cancer genomes.
Poulos RC; Olivier J; Wong JWH
Nucleic Acids Res; 2017 Jul; 45(13):7786-7795. PubMed ID: 28531315
[TBL] [Abstract][Full Text] [Related]
14. Methylation and repeats in silent and nonsense mutations of p53.
Kouidou S; Malousi A; Maglaveras N
Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
[TBL] [Abstract][Full Text] [Related]
15. 1995 Deichmann Lecture--p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology and cancer risk assessment.
Harris CC
Toxicol Lett; 1995 Dec; 82-83():1-7. PubMed ID: 8597035
[TBL] [Abstract][Full Text] [Related]
16. Conserved nonsense-prone CpG sites in apoptosis-regulatory genes: conditional stop signs on the road to cell death.
Zhao Y; Epstein RJ
Evol Bioinform Online; 2013; 9():275-83. PubMed ID: 23908585
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in colorectal cancer are associated with the epigenetic modifications.
Lei H; Tao K
J Cell Mol Med; 2020 Oct; 24(20):11828-11836. PubMed ID: 32865336
[TBL] [Abstract][Full Text] [Related]
18. Germ line mutations of hMSH2 and hMLH1 genes in Japanese families with hereditary nonpolyposis colorectal cancer (HNPCC): usefulness of DNA analysis for screening and diagnosis of HNPCC patients.
Miyaki M; Konishi M; Muraoka M; Kikuchi-Yanoshita R; Tanaka K; Iwama T; Mori T; Koike M; Ushio K; Chiba M
J Mol Med (Berl); 1995 Oct; 73(10):515-20. PubMed ID: 8581513
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
20. Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers.
Tornaletti S; Pfeifer GP
Oncogene; 1995 Apr; 10(8):1493-9. PubMed ID: 7731703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
